Suzhou Fengbei Biotech Stock Co., Ltd. (SHA:603334)
China
· Delayed Price · Currency is CNY 50.31
+1.58 (3.24%)
Apr 29, 2026, 3:00 PM CST
SHA:603334 Market Cap
SHA:603334 has a market cap or net worth of 7.22 billion as of April 29, 2026.
Market Cap
7.22B
Enterprise Value
6.61B
Revenue
3.17B
Ranking
n/a
PE Ratio
40.57
Stock Price
50.31
Market Cap Chart
Since November 5, 2025, SHA:603334's market cap has decreased from 9.58B to 7.22B, a decrease of -24.64%. That is a compound annual growth rate of -44.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 6.99B | 16.58% |
| Dec 31, 2025 | 6.00B | -37.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengdu Kanghua Biological Products | 7.43B |
| Jiangsu Aidea Pharmaceutical Group | 7.44B |
| Anhui Huaheng Biotechnology | 6.94B |
| Wuhan Keqian Biology Co.,Ltd | 6.85B |
| Shanghai OPM Biosciences | 6.82B |
| Nanjing Vazyme Biotech | 7.64B |
| Acrobiosystems | 7.69B |
| Xiangxue Pharmaceutical | 6.66B |